Skip to main content

Clinical trial JAVELIN Bladder Medley

A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab (MSB0010718C) in Combination with Other Anti-Tumor Agents as a Maintenance Treatment in Participants with Locally Advanced or Metastatic Urothelial Carcinoma Whose Disease Did Not Progress with First Line Platinum-Containing Chemotherapy

Organ Multiple
Trial status Trial open for recruitment
Trial type
Interventional with experimental drug
Phase Trial phase 2
Academic trial Non
Sponsor Merck
EudraCT Identifier 2021-003669-36
Last update